Filing Details
- Accession Number:
- 0001237899-10-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-08 12:49:25
- Reporting Period:
- 2010-10-06
- Filing Date:
- 2010-10-08
- Accepted Time:
- 2010-10-08 12:49:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-06 | 5,000 | $18.80 | 34,662 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-10-06 | 3,235 | $29.05 | 31,427 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-10-07 | 1,765 | $28.03 | 29,662 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-10-06 | 5,000 | $0.00 | 5,000 | $18.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2013-01-02 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 1,765 shares of Company stock on October 7, 2010 at prices ranging from $28.00 to $28.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 7, 2010 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.